Clinical Trials for CLL Patients 65 and Older

patientpower has 2382 videos Subscribe Here

Description: In this video, Dr. Joseph Flynn suggests that overall health is far more important for trial eligibility than a patient's age and encourages CLL patients over 65 years old to inquire about clinical studies. Dr. Flynn explains that ongoing trials for Kinase Inhibitors like PCI-32765 and GS-1101 may be of particular benefit to this group of patients as the treatments are far less toxic than the chemotherapy-based drugs that make up the current standard of care.
Shared By : patientpower
Posted on : 05/18/12
Added : 6 years ago
Category : Other